Emedastine difumarate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for emedastine difumarate and what is the scope of patent protection?
Emedastine difumarate
is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for emedastine difumarate.
Summary for emedastine difumarate
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 50 |
| Patent Applications: | 2,151 |
| DailyMed Link: | emedastine difumarate at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for emedastine difumarate
US Patents and Regulatory Information for emedastine difumarate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | EMADINE | emedastine difumarate | SOLUTION/DROPS;OPHTHALMIC | 020706-001 | Dec 29, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for emedastine difumarate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Novartis | EMADINE | emedastine difumarate | SOLUTION/DROPS;OPHTHALMIC | 020706-001 | Dec 29, 1997 | ⤷ Sign Up | ⤷ Sign Up |
| Novartis | EMADINE | emedastine difumarate | SOLUTION/DROPS;OPHTHALMIC | 020706-001 | Dec 29, 1997 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
